These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 11850865)

  • 1. Severe nucleoside-associated lactic acidosis in human immunodeficiency virus-infected patients: report of 12 cases and review of the literature.
    Falcó V; Rodríguez D; Ribera E; Martínez E; Miró JM; Domingo P; Diazaraque R; Arribas JR; González-García JJ; Montero F; Sánchez L; Pahissa A
    Clin Infect Dis; 2002 Mar; 34(6):838-46. PubMed ID: 11850865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detecting life-threatening lactic acidosis related to nucleoside-analog treatment of human immunodeficiency virus-infected patients, and treatment with L-carnitine.
    Claessens YE; Cariou A; Monchi M; Soufir L; Azoulay E; Rouges P; Goldgran-Toledano D; Branche F; Dhainaut JF
    Crit Care Med; 2003 Apr; 31(4):1042-7. PubMed ID: 12682470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nucleoside analogue-induced fatal lactic acidosis in two HIV-infected patients in Singapore.
    Hwang SW; Leo YS
    Singapore Med J; 2001 Jun; 42(6):247-51. PubMed ID: 11547960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lactic acidemia in infection with human immunodeficiency virus.
    Carr A
    Clin Infect Dis; 2003 Apr; 36(Suppl 2):S96-S100. PubMed ID: 12652378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Symptomatic hyperlactatemia associated with nucleoside analogue reverse-transcriptase inhibitor use in HIV-infected patients: a report of 24 cases in a resource-limited setting (Uganda).
    Songa PM; Castelnuovo B; Mugasha EB; Ocama P; Kambugu A
    Clin Infect Dis; 2007 Aug; 45(4):514-7. PubMed ID: 17638205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for lactic acidosis in HIV-infected patients treated with nucleoside reverse-transcriptase inhibitors: a case-control study.
    Bonnet F; Bonarek M; Morlat P; Mercié P; Dupon M; Gemain MC; Malvy D; Bernard N; Pellegrin JL; Beylot J
    Clin Infect Dis; 2003 May; 36(10):1324-8. PubMed ID: 12746780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fatal lactic acidosis during antiretroviral therapy.
    Rey C; Prieto S; Medina A; Pérez C; Concha A; Menéndez S
    Pediatr Crit Care Med; 2003 Oct; 4(4):485-7. PubMed ID: 14525648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperlactataemia and lactic acidosis in HIV-infected patients receiving antiretroviral therapy.
    Calza L; Manfredi R; Chiodo F
    Clin Nutr; 2005 Feb; 24(1):5-15. PubMed ID: 15681097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Symptomatic lactic acidosis in hospitalized antiretroviral-treated patients with human immunodeficiency virus infection: a report of 12 cases.
    Coghlan ME; Sommadossi JP; Jhala NC; Many WJ; Saag MS; Johnson VA
    Clin Infect Dis; 2001 Dec; 33(11):1914-21. PubMed ID: 11692304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fatal lactic acidosis associated with highly active antiretroviral therapy in patients with advanced human immunodeficiency virus infection in Taiwan.
    Sheng WH; Hsieh SM; Lee SC; Chen MY; Wang JT; Hung CC; Chang SC
    Int J STD AIDS; 2004 Apr; 15(4):249-53. PubMed ID: 15075019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonalcoholic fatty liver disease in HIV-infected patients referred to a metabolic clinic: prevalence, characteristics, and predictors.
    Guaraldi G; Squillace N; Stentarelli C; Orlando G; D'Amico R; Ligabue G; Fiocchi F; Zona S; Loria P; Esposito R; Palella F
    Clin Infect Dis; 2008 Jul; 47(2):250-7. PubMed ID: 18532884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for mortality in symptomatic hyperlactatemia among HIV-infected patients receiving antiretroviral therapy in a resource-limited setting.
    Manosuthi W; Prasithsirikul W; Chumpathat N; Suntisuklappon B; Athichathanabadi C; Chimsuntorn S; Sungkanuparph S
    Int J Infect Dis; 2008 Nov; 12(6):582-6. PubMed ID: 18337140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bench-to-bedside review: severe lactic acidosis in HIV patients treated with nucleoside analogue reverse transcriptase inhibitors.
    Claessens YE; Chiche JD; Mira JP; Cariou A
    Crit Care; 2003 Jun; 7(3):226-32. PubMed ID: 12793872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperlactataemia in HIV-infected patients: the role of NRTI-treatment.
    Vrouenraets SM; Treskes M; Regez RM; Troost N; Smulders YM; Weigel HM; Frissen PH; Brinkman K
    Antivir Ther; 2002 Dec; 7(4):239-44. PubMed ID: 12553477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochondrial toxicity: myths and facts.
    Moyle G
    J HIV Ther; 2004 May; 9(2):45-7. PubMed ID: 15238876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Type B lactic acidosis in an AIDS patient treated with zidovudine.
    Aggarwal A; al-Talib K; Alabrash M
    Md Med J; 1996 Nov; 45(11):929-31. PubMed ID: 8942169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondrial toxicity associated with HAART following liver transplantation in an HIV-infected recipient.
    Antoniades C; Macdonald C; Knisely A; Taylor C; Norris S
    Liver Transpl; 2004 May; 10(5):699-702. PubMed ID: 15108264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of Tris-hydroxymethyl aminomethane in severe lactic acidosis due to highly active antiretroviral therapy: a case report.
    Marfo K; Garala M; Kvetan V; Gasperino J
    J Clin Pharm Ther; 2009 Feb; 34(1):119-23. PubMed ID: 19125910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A high incidence of lactic acidosis and symptomatic hyperlactatemia in women receiving highly active antiretroviral therapy in Soweto, South Africa.
    Bolhaar MG; Karstaedt AS
    Clin Infect Dis; 2007 Jul; 45(2):254-60. PubMed ID: 17578788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperlactatemia in human immunodeficiency virus-uninfected infants who are exposed to antiretrovirals.
    Noguera A; Fortuny C; Muñoz-Almagro C; Sanchez E; Vilaseca MA; Artuch R; Pou J; Jimenez R
    Pediatrics; 2004 Nov; 114(5):e598-603. PubMed ID: 15492359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.